Nature Communications (May 2022)

Nanoparticle-enhanced radiotherapy synergizes with PD-L1 blockade to limit post-surgical cancer recurrence and metastasis

  • Xin Guan,
  • Liping Sun,
  • Yuting Shen,
  • Fengshan Jin,
  • Xiaowan Bo,
  • Chunyan Zhu,
  • Xiaoxia Han,
  • Xiaolong Li,
  • Yu Chen,
  • Huixiong Xu,
  • Wenwen Yue

DOI
https://doi.org/10.1038/s41467-022-30543-w
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 17

Abstract

Read online

Tumor recurrence after surgical resection is associated with a poor clinical outcome. Here the authors design a manganese dioxide-based nanosystem to increase response to radio-immunotherapy by relieving tumor hypoxia and targeting myeloid cells, showing reduced post-surgical cancer recurrence and metastasis.